Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 945 of 1,261

  1. US 8062654

    Drug releasing biodegradable fiber for delivery of therapeutics

    The Board of Regents of the University of Texas System · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  2. US 8063047

    Pyridazine compounds and methods

    Northwestern University · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted

  3. US 8058257

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Alnylam Pharmaceuticals, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  4. US 8058385

    Method for preparing conjugates using polymer maleimides

    Nektar Therapeutics · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  5. US 8057810

    Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application

    Obschestvo S Ogranichennoi Otvetstvennostyu “Sia Peptides” · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  6. US 8058403

    Antibodies to stromal cell-derived factor-1 polypeptides

    Five Prime Therapeutics, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  7. US 8058268

    Neuroprotective agents for the prevention and treatment of neurodegenerative diseases

    Lixte Biotechnology, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  8. US 8058226

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  9. US 8057807

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    The Regents of the University of Colorado, a Body Corporate · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  10. US 8058295

    Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof

    The Regents of the University of California · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  11. US 8058271

    Selective inhibitors of rock protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  12. US 8058249

    Immunostimulatory nucleic acid molecules

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  13. US 8058280

    Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  14. US 8058300

    Polycyclic antagonists of lysophosphatidic acid receptors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  15. US 8058248

    Foot and mouth disease virus vaccine comprising interferons

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  16. US 8058244

    Cyclic peptide antitumor agents

    Northwestern University · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  17. US 8058237

    Stable composition of GDF-5 and method of storage

    Advanced Technologies and Regenerative Medicine, LLC · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  18. US 8058025

    Methods for determining efficacy of chemotherapeutic agents

    Precision Therapeutics, Inc. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  19. US 8058063

    Method of producing region-specific neurons from human neuronal stem cells

    The Board of Regents of the University of Texas System · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  20. US 8057990

    Screening method

    Takeda Pharmaceutical Company Limited · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  21. US 8058446

    Certain substituted amides, method of making, and method of use thereof

    GILEAD CONNECTICUT, INC. · Granted Nov 15, 2011 · Expires Nov 10, 2031

    granted

  22. US 8053424

    Composition and method of treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  23. US 8053434

    Kinase inhibitors and their uses

    Rigel Pharmaceuticals, Inc. · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

  24. US 8052970

    Lysosomal phospholipase A2 (LPLA2) activity as a diagnostic and therapeutic target for identifying and treating systemic lupus erythematosis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 8, 2011 · Expires Nov 3, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.